AU2021436402B2 - Infectious disease testing method - Google Patents

Infectious disease testing method Download PDF

Info

Publication number
AU2021436402B2
AU2021436402B2 AU2021436402A AU2021436402A AU2021436402B2 AU 2021436402 B2 AU2021436402 B2 AU 2021436402B2 AU 2021436402 A AU2021436402 A AU 2021436402A AU 2021436402 A AU2021436402 A AU 2021436402A AU 2021436402 B2 AU2021436402 B2 AU 2021436402B2
Authority
AU
Australia
Prior art keywords
facility
collecting
sample
information
period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021436402A
Other languages
English (en)
Other versions
AU2021436402A1 (en
Inventor
Fumi DAIGO
Hiroaki TAKEMORI
Takuya TOMONO
Makoto YASOJIMA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shimadzu Corp
Original Assignee
Shimadzu Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimadzu Corp filed Critical Shimadzu Corp
Publication of AU2021436402A1 publication Critical patent/AU2021436402A1/en
Application granted granted Critical
Publication of AU2021436402B2 publication Critical patent/AU2021436402B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/02—Devices for withdrawing samples
    • G01N1/10—Devices for withdrawing samples in the liquid or fluent state
    • G01N1/20—Devices for withdrawing samples in the liquid or fluent state for flowing or falling materials
    • G01N1/2035—Devices for withdrawing samples in the liquid or fluent state for flowing or falling materials by deviating part of a fluid stream, e.g. by drawing-off or tapping
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/26—Inoculator or sampler
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Sustainable Development (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hydrology & Water Resources (AREA)
  • Data Mining & Analysis (AREA)
  • Toxicology (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AU2021436402A 2021-03-25 2021-06-18 Infectious disease testing method Active AU2021436402B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021052117 2021-03-25
JP2021-052117 2021-03-25
PCT/JP2021/023270 WO2022201567A1 (ja) 2021-03-25 2021-06-18 感染症検査方法

Publications (2)

Publication Number Publication Date
AU2021436402A1 AU2021436402A1 (en) 2023-10-12
AU2021436402B2 true AU2021436402B2 (en) 2025-06-26

Family

ID=82849858

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021436402A Active AU2021436402B2 (en) 2021-03-25 2021-06-18 Infectious disease testing method

Country Status (6)

Country Link
US (1) US20240142350A1 (enExample)
EP (1) EP4317395A4 (enExample)
JP (4) JP7031957B1 (enExample)
CN (1) CN116997662A (enExample)
AU (1) AU2021436402B2 (enExample)
WO (1) WO2022201567A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023210597A1 (ja) * 2022-04-25 2023-11-02 株式会社島津テクノリサーチ 試料採取装置
JPWO2024185253A1 (enExample) * 2023-03-08 2024-09-12

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319543A (en) * 1992-06-19 1994-06-07 First Data Health Services Corporation Workflow server for medical records imaging and tracking system
JPH11256543A (ja) * 1998-03-13 1999-09-21 Hitachi Ltd 感染症病原リスク管理マッピングシステム
US7399447B2 (en) 2004-04-01 2008-07-15 Enigma Science, Llc Active sampler for detecting contaminants in liquids
CN201395237Y (zh) 2009-03-27 2010-02-03 北京师范大学 应用于突发性污染河流应急处理的竹排式吸附筏
DE102009042056B4 (de) * 2009-09-15 2021-02-04 Mirion Technologies (Canberra CA) Ltd. Verfahren zur Erfassung einer Kontamination an einem bewegten Objekt
JP5636685B2 (ja) * 2010-02-02 2014-12-10 独立行政法人水産総合研究センター ノロウイルス検出用材料および該材料を用いるノロウイルスの検出方法
CN202297198U (zh) 2011-09-30 2012-07-04 北京师范大学 对溢油污染海水具有吸附功能的可生物降解浮床
JP2015143924A (ja) * 2014-01-31 2015-08-06 ケーディーアイコンズ株式会社 情報処理装置及びプログラム
EP3570315B1 (en) * 2015-03-06 2024-01-31 Micromass UK Limited Rapid evaporative ionisation mass spectrometry ("reims") and desorption electrospray ionisation mass spectrometry ("desi-ms") analysis of biopsy samples
US20200385296A1 (en) * 2019-06-04 2020-12-10 Biobot Analytics, Inc. Method for characterizing the prevalence of a biochemical condition within a population
CN111444279B (zh) * 2020-04-03 2023-04-21 长春市万易科技有限公司 一种基于区块链的人员流动记录系统及方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAMOUDA, M., ET AL. "Wastewater surveillance for SARS-CoV-2: Lessons learnt from recent studies to define future applications", SCI TOTAL ENVIRON, 2020, vol. 759. 143493 *

Also Published As

Publication number Publication date
US20240142350A1 (en) 2024-05-02
JP7582272B2 (ja) 2024-11-13
JP2025016645A (ja) 2025-02-04
WO2022201567A1 (ja) 2022-09-29
JP2022151884A (ja) 2022-10-07
AU2021436402A1 (en) 2023-10-12
JP7118370B1 (ja) 2022-08-16
JP7031957B1 (ja) 2022-03-08
JP2022151641A (ja) 2022-10-07
JPWO2022201567A1 (enExample) 2022-09-29
EP4317395A1 (en) 2024-02-07
EP4317395A4 (en) 2024-09-11
CN116997662A (zh) 2023-11-03

Similar Documents

Publication Publication Date Title
Keshaviah et al. Developing a flexible national wastewater surveillance system for COVID-19 and beyond
Müller‐Staub et al. Nursing diagnoses, interventions and outcomes–application and impact on nursing practice: systematic review
Razum et al. How useful is a name‐based algorithm in health research among Turkish migrants in Germany?
Fitzhenry et al. Legionnaires’ disease outbreaks and cooling towers, New York city, New York, USA
World Health Organization Environmental surveillance for SARS-COV-2 to complement public health surveillance: interim guidance, 14 April 2022
JP2025016645A (ja) 感染症検査方法
Smith et al. Legionellosis outbreak associated with a hotel fountain
Kirrage et al. Investigation of an outbreak of Legionnaires’ disease: Hereford, UK 2003
Vlachos et al. School closures and SARS-CoV-2. Evidence from Sweden’s partial school closure
Maal-Bared et al. To sample or not to sample: A governance-focused decision tree for wastewater service providers considering participation in wastewater-based epidemiology (WBE) in support of public health programs
Akinyinka et al. Community perception of quality of health care received and client satisfaction in Lagos, Nigeria
Agol et al. Sanitation and water supply in schools and girls' educational progression in Zambia
Martin et al. Influenza‐like illness‐related emergency department visits: Christmas and New Year holiday peaks and relationships with laboratory‐confirmed respiratory virus detections, Edmonton, Alberta, 2004–2014
Saravia et al. Wastewater-based epidemiology: deriving a SARS-CoV-2 data validation method to assess data quality and to improve trend recognition
Alombah et al. Effect of supportive supervision on malaria microscopy competencies in sub-Saharan Africa
Ugas et al. Examining the factors related to bacteriological testing of private wells in Southern Ontario
Craun et al. Improving waterborne disease outbreak investigations
Rao et al. Vulnerability assessment in slums of union territory, Chandigarh
Tancredi et al. Designing surveillance at a population level
Gleason et al. Development and evaluation of statewide prospective spatiotemporal legionellosis cluster surveillance, New Jersey, USA
Wilson Assuring the quality of clinical microbiology test results
Crump et al. Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases
Jacobs et al. Transfusion‐transmitted malaria in India: A national survey of epidemiology and testing practices
Deress et al. Customer satisfaction with clinical laboratory services provided by the Ethiopian health facilities: a systematic review and meta-analysis
Ngowi et al. Testers' compliance to the quality standards of HIV rapid testing services in Primary Health Care Facilities in Makete District, Tanzania

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)